trimethoprim has been researched along with ciprofloxacin in 197 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (15.23) | 18.7374 |
| 1990's | 23 (11.68) | 18.2507 |
| 2000's | 47 (23.86) | 29.6817 |
| 2010's | 73 (37.06) | 24.3611 |
| 2020's | 24 (12.18) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Keserü, GM | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Jones, GL; Stickler, DJ | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Biedenbach, DJ; Fritsche, TR; Jones, RN | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| Ahmed, S; Calderwood, SB; Faruque, AS; Hooper, DC; Jacoby, GA; Khan, WA; Kim, HB; LaRocque, RC; Park, CH; Qadri, F; Salam, MA; Wang, M | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Avdeef, A; Tam, KY | 1 |
| Bremont, S; Courvalin, P; Hervé-Bazin, M; Le Monnier, A; Leclercq, A; Lecuit, M; Morvan, A; Moubareck, C | 1 |
| Harada, S; Ishii, Y; Saga, T; Tateda, K; Yamaguchi, K | 1 |
| Barrow, EW; Barrow, WW; Berlin, KD; Bourne, CR; Bourne, PC; Bunce, RA | 1 |
| Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Sen, S; Sinha, N | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bradford, TA; Butler, MS; Cooper, MA; Fry, SR; Huang, JX; Karoli, T; Madala, PK; Mamidyala, SK; Ramu, S; Tee, EH; Zuegg, J | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Anjum, MN; Arfan, M; Ayaz, M; Batool Kazmi, ST; Farooq, S; Haq, IU; Iftikhar, F; Rashid, U; Ullah, A | 1 |
| Bera, S; Mondal, D | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Cooper, DL; He, H; Lovett, ST; Shy, A; Sun, S; Wang, J; Wu, D; Xu, B; Xu, J; Zhan, W | 1 |
| Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Dolensky, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Petritsch, M; Saf, R; Schühly, W; Seebacher, W; Weis, R | 1 |
| Yolton, DP | 1 |
| Hooper, DC; Huovinen, P; Wolfson, JS | 1 |
| Aagaard, J; Gasser, T; Madsen, PO; Rhodes, P | 1 |
| Ferro, S; Low, DE; Simor, AE | 1 |
| Benonisen, E; Dibb, WL; Digranes, A | 1 |
| Dent, J; McNulty, CA; Wise, R | 1 |
| Boerema, JB | 1 |
| Ariza, J; Bosch, J; Cisnal, MC; Liñares, J; López de Goicoechea, MJ; Martin, R | 1 |
| Forsgren, A; Persson, KM | 1 |
| Nevárez, M; Ramírez-Ronda, CH; Saavedra, S | 1 |
| Birnbaum, D; Krause, B; Lenk, V; Trautmann, M; Wagner, J | 1 |
| Kapell, KS; Kessler, HA; Segreti, J; Trenholme, GM | 1 |
| Dekker, A; Rozenberg-Arska, M; Verhoef, J | 1 |
| Hohl, P; Kafader, FM; Salfinger, M | 1 |
| Andrews, JM; Ashby, JP; Matthews, RS; Wise, R | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Cullmann, W; Dechène, M; Stieglitz, M | 1 |
| Dubois, J; Fontaine, V | 1 |
| Brittain, DC; Labthavikul, P; McElrath, MJ; Neu, HC; Scully, BE; Steinman, R | 1 |
| Allais, JM; Bittner, MJ; Cuevas, TA; Mellencamp, MA; Preheim, LC; Roccaforte, JS | 1 |
| Chan, V; Noble, MA | 1 |
| Bourgeois, AL; Hyams, KC; Lissner, CR; Mikhail, IA; Podgore, JK; Walz, S | 1 |
| Dekker, AW; Rozenberg-Arska, M | 1 |
| Dekker, AW; Rozenberg-Arska, M; Verhoef, J | 1 |
| Grubbs, NC; Henry, NK; Ilstrup, DM; Muller, SM; Schultz, HJ; Wilson, WR | 1 |
| Grüneberg, RN; Williams, AH | 1 |
| Bitsura, JA; de la Cabada, FJ; Dupont, HL; Ericsson, CD; Johnson, PC; Morgan, DR | 1 |
| Matthews, J; Murphy, P; Newsom, SW | 1 |
| Andriole, VT; Berenson, CS; Greco, TP; Mangi, RJ; Ryan, JL; Sims, M; Thornton, GF | 1 |
| D'Costa, LJ; Greenblatt, RM; Naamara, W; Ndinya-Achola, JO; Plummer, FA; Ronald, AR | 1 |
| DuPont, HL; Ericsson, CD; Johnson, PC; Robinson, A | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Arduino, RC; Frosolono, M; Murray, BE | 1 |
| Behets, FM; Cohen, MS; Dallabetta, G; Hamilton, HA; Hoffman, IF; Liomba, G; Lule, G; Moeng, S | 1 |
| Helander, I; Huovinen, P; Huovinen, S; Järvinen, H; Kotilainen, P; Malanin, K; Sarna, S | 1 |
| Ismaeel, NA | 1 |
| Beumer, H; Hoepelman, AI; Rozenberg-Arska, M; Verhoef, J; Visser, MR | 1 |
| Coleman, K; Durodie, J; Loughborough, SH; Simpson, IN; Winstanley, DW | 1 |
| Florio, A; Locatelli, A; Rambaldi, A; Rosario, P; Ruggiero, G; Tripodi, MF; Utili, R | 1 |
| Hellström, P; Kontturi, M; Leppilahti, M; Lukkarinen, O; Tammela, T | 1 |
| Jones, D; Leahey, AB | 1 |
| Barry, JJ; Burns, JL; Goodall, CP; Wadsworth, CD | 1 |
| Richards, RM; Xing, JZ | 1 |
| Akalin, E; Arikan, S; Auckenthaler, R; Bergan, T; Dornbusch, K; Howard, AJ; Hryniewicz, W; Jones, RN; Koupari, G; Legakis, NJ; McLaughlin, J; Ozkuyumcu, C; Percival, A; Phillips, I; Reeves, D; Spencer, R; Warren, RE; Williams, JD; Yeo, SF | 1 |
| Frisk, A; Lagergård, T; Trollfors, B | 1 |
| Kong, CH; Lee, SW; Li, RC | 1 |
| Hannesson, OB; Kristinsson, JK; Sveinsson, O; Thorleifsson, H | 1 |
| Caparros-Wanderley, W; Ebringer, A; Senior, BW; Tiwana, H; Wilson, C | 1 |
| Denstedt, JD; Reid, G; Riddell, JV; Tieszer, C; Wollin, TA | 1 |
| Amyes, SG; Cakir, N; Gülay, Z; Mehr, MA; Yüce, A; Yulug, N | 1 |
| Hamilton, VE; Richards, RM; Thomas, MR | 1 |
| Hartzema, AG; Huang, X; Kauf, TL; Norwood, GJ; Raasch, RH | 1 |
| Threlfall, EJ | 1 |
| Andersen, HR; Halling-Sørensen, B; Ingerslev, F; Lützhøft, HC | 1 |
| Dunstan, FD; Fitzgerald, KA; Howard, AJ; Magee, JT | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
| Balagué, C; Fernández, L; Grau, R; Pérez, J | 1 |
| Donnenfeld, ED; O'Brien, TP; Perry, HD; Solomon, R; Speaker, MG; Wittpenn, J | 1 |
| Shaikh, N; Tarr, PI | 1 |
| Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
| Honkanen-Buzalski, T; Lehtolainen, T; Pyörälä, S; Shpigel, NY; Shwimmer, A | 1 |
| Burns, JL; Cheung, KJ; Griffith, A; Nair, BM | 1 |
| Mandal, MD; Mandal, S; Pal, NK | 1 |
| Amábile-Cuevas, CF; Arredondo-García, JL; Cardeñosa-Guerra, O; Corral, M; Costa, A; Figueroa-Damián, R; Hernández-Oliva, GM; Jáuregui, A; Merlos, RM; Olguín, J; Ríos-Fabra, A; Rosas, A | 1 |
| Biswal, M; Sharma, M; Taneja, N; Tarai, B | 1 |
| Aga, DS; Batt, AL; Bruce, IB | 1 |
| Goerke, C; Köller, J; Wolz, C | 1 |
| Gans, O; González-Barreiro, C; Martínez-Carballo, E; Scharf, S | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Berger-Bächi, B; Ender, M; McCallum, N | 1 |
| Anderson, G; Call, V; Foley, SL; Kaldhone, P; Kerdahi, K; Nayak, R; Phillips, S; Tyler, C | 1 |
| Johnson, MI; Lennon, T; Masters, J; Matthews, JN; Merrilees, D; Neal, DE; Orr, KE; Robson, WA | 1 |
| Hori, S; Kennedy, CL | 1 |
| Biesiada, G; Czepiel, J; Garlicki, A; Mach, T; Salamon, D; Skwara, P; Sobczyk-Krupiarz, I | 1 |
| Chowdhury, IH; Debmandal, M; Mandal, S; Pal, NK | 1 |
| Blázquez, J; López, E | 1 |
| Bennett, K; Cormican, M; Hanahoe, B; Murphy, AW; Vellinga, A | 1 |
| Fuller, CA; McGannon, CM; Weiss, AA | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Hu, L; Martin, HM; Strathmann, TJ | 1 |
| Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
| Jayaraman, P; Lim, CS; Sakharkar, KR; Sakharkar, MK; Tang, TH | 1 |
| Burström, B; Ericsson, O; Ljung, R; Reimers, A | 1 |
| Hu, L; Stemig, AM; Strathmann, TJ; Wammer, KH | 1 |
| Gach, JE; Kaur, MR; Suortamo, S; Wong, L | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Dimopoulou, D; Falagas, ME; Karageorgopoulos, DE; Kofteridis, DP; Levis, P; Maraki, S; Samonis, G; Spernovasilis, NA | 1 |
| Ahmad, S; Cullen, IM; Fennell, JP; Flynn, R; Grainger, R; Manecksha, RP; McCullagh, E; McDermott, TE; Murphy, P; O'Kelly, F; Thornhill, JA | 1 |
| Bennett, K; Cormican, M; Hanahoe, B; Murphy, AW; Tansey, S; Vellinga, A | 1 |
| Alam, M; Colwell, RR; Cravioto, A; Huq, A; Islam, MT; Johura, FT; Mannan, SB; Rashed, SM; Sack, RB; Sadique, A; Watanabe, H | 1 |
| Bleidorn, J; Gágyor, I; Hummers-Pradier, E; Schmiemann, G | 1 |
| Ekin, IH; Ilhan, Z; Solmaz, H | 1 |
| Edquist, P; Giske, CG; Liljequist, BO; Ringman, M; Wisell, KT | 1 |
| Chen, F; Chen, H; Fu, W; Luo, W; Meng, F; Xie, Y; Yang, X; Ye, T; Young, K | 1 |
| Kadlec, MW; Liao, JC; Wong, PK; You, D | 1 |
| Duffy, B; Walsh, F | 1 |
| An, XP; Fan, HL; Guan, H; Li, PF; Shen, JZ; Zhao, HX; Zhao, JL | 1 |
| Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
| Blaha, L; Dalla Bona, M; De Liguoro, M; Merlanti, R; Zounková, R | 1 |
| Dumont, E; Johnson, AC; Keller, V; Sumpter, JP | 1 |
| Dalsgaard, A; Phu, TM; Phuong, NT; Scippo, ML | 1 |
| Brair, A; Gray, J; Toozs-Hobson, P | 1 |
| Jagannadham, MV; Kulkarni, HM; Nagaraj, R | 1 |
| Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA | 1 |
| D'Souza, S; Kang, TM; Lam, K; Miller, JH; Song, LY; Yeh, P | 1 |
| Gallert, C; Heß, S | 1 |
| Baym, M; Chait, R; Gross, R; Kelsic, ED; Kishony, R; Lieberman, TD; Yelin, I | 1 |
| Cason, L; Chalasani, P; Dahya, V; Kuretski, J; Ramgopal, M | 1 |
| Campo, RD; Carrola, J; Carvalho, I; Carvalho, S; Cobo, M; Igrejas, G; Marinho, C; Nóvoa, M; Pereira, JE; Poeta, P; Quaresma, M; Santos, T; Silva, N; Sousa, M | 1 |
| Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
| Demirel, I; Kruse, R; Persson, K; Sahlberg Bang, C | 1 |
| Barry, L; Corcoran, GD; Hooton, C; Lucey, B; O'Grady, MC; O'Halloran, C; Walsh, N | 1 |
| Bao, X; Chan, HK; Chan, T; Li, J; Lu, X; Velkov, T; Zhou, F; Zhou, QT; Zhu, L | 1 |
| Ari, E; Bálint, B; Balogh, D; Bihari, P; Csörgő, B; Draskovits, G; Ferenc, G; Kalapis, D; Kintses, B; Nagy, I; Nyerges, Á; Pál, C; Papp, B; Papp, H; Révész, T; Számel, M; Szili, P; Vásárhelyi, BM | 1 |
| Cattrall, JWS; Kirby, A; Robinson, AV | 1 |
| Fredheim, EGA; Johnsen, PJ; Kloos, J; Podnecky, NL; Primicerio, R; Roberts, AP; Rozen, DE; Samuelsen, Ø; Sørum, V | 1 |
| Asbell, PA; DeCory, HH | 1 |
| Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S | 1 |
| Gaze, WH; Murray, AK; Snape, J; Zhang, L | 1 |
| Ben-Ari, Y; Ben-Shalom, G; Ben-Shimol, S; Cavari, Y; Geffen, Y; Goldberg, L; Keller, N; Lazar, I; Nahum, E; Paret, G; Pessach, IM; Rubinstein, M; Tokatly Latzer, I | 1 |
| Blimkie, T; Coleman, SR; Falsafi, R; Hancock, REW | 1 |
| Cizmas, L; Feng, M; Kovalakova, P; Marsalek, B; McDonald, TJ; Sharma, VK | 1 |
| Li, H; Ryser, ET; Shen, Y; Zhang, W | 1 |
| Bottega, A; Coelho, SS; Foletto, VS; Hörner, R; Lorenzoni, VV; Machado, CS; Mainardi, A; Rampelotto, RF; Rosa, TFD; Serafin, MB | 1 |
| Cummins, E; Monahan, C; Morris, D; Nag, R | 1 |
| Álvarez-Rodríguez, E; Arias-Estévez, M; Cela-Dablanca, R; Fernández-Calviño, D; Núñez-Delgado, A; Rodríguez-López, L | 1 |
| Dhandapani, R; Muthupandian, S; Palanivel, V; Paramasivam, R; Rahuman, HBH; Thangavelu, S | 1 |
| Barak Levitt, J; Barmatz, S; Dalal, A; Fisch-Gilad, S; Hackett, A; Hodak, E; Kremer, N; Levi, A; Pavlovsky, L; Sherman, S; Taieb, Y; Yahav, D | 1 |
| Green, MD; Khanthavong, M; Mayxay, M; Newton, PN; Phonlavong, C; Sengaloundeth, S; Sichanh, C; Swamidoss, I; Tabernero, P; Vilayhong, C | 1 |
| Mabiki, F; Malebo, HM; Mariki, EE; Mdegela, R; Mwankuna, CJ; Styrishave, B; Uwamaliya, GA | 1 |
| Boncz, MÁ; López-Serna, R; Muñoz, R; Ruas, G; Scarcelli, PG; Serejo, ML | 1 |
| Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K | 1 |
| Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
| Álvarez-Rodríguez, E; Arias-Estévez, M; Díaz-Raviña, M; Fernández-Calviño, D; García-Campos, E; Martín, Á; Núñez-Delgado, A; Rodríguez-González, L; Santás-Miguel, V | 1 |
| Blasco, J; Colás-Ruiz, NR; Fernandez, R; Hampel, M; Lara-Martín, PA; Mancera, JM; Martínez-Rodríguez, G; Trombini, C | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Chang, SC; Hidrosollo, JH; Kao, CY; Lin, LC; Lu, JJ; Ou, YH | 1 |
| Mishra, V; Ojha, AK; Shah, NP | 1 |
| Dawson, C; McPherson, F; O'Flaherty, C; Revitt-Mills, SA; Robinson, A; van Oijen, AM; Vereker, M; Wright, EK | 1 |
| Álvarez-Rodríguez, E; Arias-Estévez, M; Díaz-Raviña, M; Fernández-Calviño, D; Núñez-Delgado, A; Rodríguez-González, L; Santás-Miguel, V | 1 |
| Liao, Q; Luo, L; Qian, M; Wang, J; Wu, H; Xiang, J; Yuan, L; Zhang, D; Zhang, L; Zhou, M | 1 |
| Hassoubah, SA | 1 |
| Choi, HJ; Choi, JY; Choi, YH; Kim, C; Park, RW; Rhie, SJ | 1 |
10 review(s) available for trimethoprim and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
New antibacterial drugs for topical ophthalmic use.
Topics: Ciprofloxacin; Conjunctivitis, Bacterial; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Norfloxacin; Ophthalmic Solutions; Polymyxin B; Trimethoprim | 1992 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Epidemic salmonella typhimurium DT 104--a truly international multiresistant clone.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Salmonella typhimurium; Trimethoprim | 2000 |
Infectious keratitis after photorefractive keratectomy.
Topics: Adult; Ciprofloxacin; Corneal Ulcer; Cross Infection; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Lasers, Excimer; Methicillin Resistance; Photorefractive Keratectomy; Polymyxins; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Trimethoprim; Visual Acuity | 2003 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim | 2018 |
Occurrence and toxicity of antibiotics in the aquatic environment: A review.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Aquatic Organisms; Ciprofloxacin; Ecotoxicology; Environmental Monitoring; Erythromycin; Groundwater; Risk Assessment; Sulfamethoxazole; Tetracycline; Trimethoprim; Water Pollutants, Chemical | 2020 |
Antibiotic residues in the aquatic environment - current perspective and risk considerations.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Environmental Monitoring; Humans; Trimethoprim; Water Pollutants, Chemical | 2021 |
17 trial(s) available for trimethoprim and ciprofloxacin
| Article | Year |
|---|---|
Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Infection Control; Leukemia; Neomycin; Neutropenia; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Blood Bactericidal Activity; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Gram-Negative Bacteria; Humans; Kinetics; Male; Quinolines; Random Allocation; Sulfamethizole; Time Factors; Trimethoprim | 1985 |
Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections.
Topics: Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Random Allocation; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1988 |
Ciprofloxacin for infection prevention in patients with acute leukemia.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; Drug Therapy, Combination; Humans; Leukemia; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Microbial; Humans; Leukemia; Leukemia, Lymphoid; Patient Compliance; Random Allocation; Sulfamethizole; Sulfathiazoles; Trimethoprim | 1987 |
Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women.
Topics: Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Double-Blind Method; Drug Combinations; Female; Humans; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Ciprofloxacin and co-trimoxazole in urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
Topics: Adult; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Humans; Placebos; Prospective Studies; Random Allocation; Sulfamethoxazole; Time Factors; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients.
Topics: Aged; Ciprofloxacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Humans; Prospective Studies; Trimethoprim; Urinary Tract Infections | 1986 |
Oral ciprofloxacin in resistant urinary tract infections.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.
Topics: Adolescent; Adult; Chancroid; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Current problems in antimicrobial therapy for bacterial enteric infection.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Staphylococcal Infections; Time Factors; Trimethoprim; Varicose Ulcer | 1994 |
Prospective randomized open study between ciprofloxacin and a combination of sulfadiazine and trimethoprim in antibiotic prophylaxis in connection with transurethral prostatectomy.
Topics: Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Premedication; Prospective Studies; Prostatectomy; Random Allocation; Sulfadiazine; Trimethoprim; Urinary Tract Infections | 1996 |
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Latin America; Norfloxacin; Premenopause; Prospective Studies; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2004 |
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy.
Topics: Administration, Oral; Adult; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Cystoscopy; Double-Blind Method; Humans; Prospective Studies; Risk Factors; Treatment Outcome; Trimethoprim | 2007 |
171 other study(ies) available for trimethoprim and ciprofloxacin
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
Topics: Anti-Bacterial Agents; Diarrhea; Dioxolanes; Fluoroquinolones; Gastroenteritis; Gram-Negative Bacteria; Humans; Piperazines; Population Surveillance; Prodrugs | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Transferable quinolone resistance in Vibrio cholerae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Vibrio cholerae | 2010 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Primers; Drug Resistance, Bacterial; Evolution, Molecular; France; Gene Transfer, Horizontal; History, 20th Century; History, 21st Century; Humans; In Vitro Techniques; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Molecular Epidemiology; Time Factors | 2010 |
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate.
Topics: beta-Lactamases; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Klebsiella pneumoniae; Molecular Sequence Data; Polymerase Chain Reaction; Proteus mirabilis; Salmonella typhimurium | 2010 |
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Microbial Sensitivity Tests; Protein Structure, Secondary; Protein Structure, Tertiary; Staphylococcus aureus; Tetrahydrofolate Dehydrogenase | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Structure aided design of chimeric antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Click Chemistry; Computer Simulation; DNA Gyrase; DNA Topoisomerase IV; Drug Design; Drug Resistance, Microbial; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Topoisomerase II Inhibitors; Triazoles; Trimethoprim | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Amino acid conjugated antimicrobial drugs: Synthesis, lipophilicity- activity relationship, antibacterial and urease inhibition activity.
Topics: Amino Acids; Anti-Bacterial Agents; Bacillus; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; Hydrophobic and Hydrophilic Interactions; Isoniazid; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Salmonella typhi; Staphylococcus aureus; Structure-Activity Relationship; Trimethoprim; Urease | 2018 |
Structure-Activity Relationship of Peptide-Conjugated Chloramphenicol for Inhibiting
Topics: Anti-Bacterial Agents; Chloramphenicol; Escherichia coli; Microbial Sensitivity Tests; Peptides; Structure-Activity Relationship | 2019 |
Preparation of new 1,3-dibenzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Candida albicans; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermis; Escherichia coli; Female; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pseudomonas aeruginosa; Quaternary Ammonium Compounds; Rats; Salts; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates.
Topics: Ciprofloxacin; Drug Synergism; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Trimethoprim | 1992 |
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids.
Topics: Animals; Body Fluids; Chronic Disease; Ciprofloxacin; Dogs; Dose-Response Relationship, Drug; Escherichia coli Infections; Humans; Hydrogen-Ion Concentration; Male; Prostatitis; Trimethoprim; Urine | 1991 |
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Nitrofurantoin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1989 |
In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Topics: 4-Quinolones; Acinetobacter; Anti-Infective Agents; Anti-Infective Agents, Urinary; Cinoxacin; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Quinolones; Trimethoprim | 1985 |
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cefoxitin; Ciprofloxacin; Erythromycin; Gastritis; Gentamicins; Humans; Metronidazole; Nalidixic Acid; Organometallic Compounds; Penicillin Resistance; Penicillins; Quinolines; Sulfamethoxazole; Tartrates; Trimethoprim | 1985 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxacin; Prostatitis; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1986 |
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Topics: Anti-Bacterial Agents; Brucella; Brucellosis; Ceftriaxone; Ciprofloxacin; Drug Combinations; Humans; Microbial Sensitivity Tests; Quinolines; Sulfamethoxazole; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Antimicrobial susceptibility of group B streptococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Quinolines; Streptococcus agalactiae; Thienamycins; Trimethoprim | 1986 |
Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.
Topics: Adult; Amoxicillin; Chloramphenicol; Ciprofloxacin; Drug Combinations; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxazines; Quinolines; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Combinations; Erythromycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Blood Proteins; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Ofloxacin; Oxazines; Protein Binding; Pseudomonas aeruginosa; Quinolines; Quinolones; Staphylococcus; Streptococcus; Trimethoprim | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Humans; Mutation; Ofloxacin; Serratia marcescens; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Ciprofloxacin; Female; Fleroxacin; Genital Diseases, Female; Genital Diseases, Male; Male; Nalidixic Acid; Penicillins; Tetracyclines; Trimethoprim; Urinary Tract Infections | 1988 |
Ciprofloxacin treatment of Salmonella hadar epididymo-orchitis.
Topics: Adult; Ciprofloxacin; Drug Combinations; Epididymitis; Humans; Male; Orchitis; Salmonella Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Diarrhea; Drug Combinations; Drug Resistance, Microbial; Egypt; Escherichia coli; Humans; Shigella; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
In-vitro activity of OPC-17116 against bacterial enteric pathogens.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Quinolones; Tetracycline; Trimethoprim | 1994 |
Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease.
Topics: Chancroid; Ciprofloxacin; Erythromycin; Genital Diseases, Male; HIV Infections; Humans; Malawi; Male; Penicillin G Benzathine; Skin Ulcer; Sulfamethoxazole; Syphilis; Trimethoprim | 1995 |
In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Topics: Anti-Bacterial Agents; Ceftriaxone; Chancroid; Ciprofloxacin; Erythromycin; Haemophilus ducreyi; Humans; Male; Microbial Sensitivity Tests; Trimethoprim | 1993 |
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Topics: Anti-Infective Agents; Bacteria; Bacterial Adhesion; Carcinoma; Ciprofloxacin; Fluoroquinolones; Humans; Laryngeal Neoplasms; Quinolones; Respiratory Tract Infections; Trimethoprim; Tumor Cells, Cultured | 1993 |
Rapid detection of antimicrobial activity using flow cytometry.
Topics: Amdinocillin; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Antimetabolites; Bacterial Proteins; Cell Size; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Escherichia coli; Flow Cytometry; Fluorescein-5-isothiocyanate; Penicillins; Ploidies; Time Factors; Trimethoprim | 1995 |
Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillins; Sulfamethoxazole; Trimethoprim | 1996 |
Haemophilus influenzae central corneal ulcer associated with cosmetic lens wear.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Polymyxin B; Trimethoprim; Visual Acuity | 1996 |
Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Base Sequence; Burkholderia cepacia; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Polyacrylamide Gel; Lipoproteins; Microbial Sensitivity Tests; Molecular Sequence Data; Trimethoprim | 1996 |
Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
Topics: Anti-Bacterial Agents; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Enzyme Inhibitors; Evaluation Studies as Topic; Folic Acid Antagonists; Gentamicins; Microbial Sensitivity Tests; Rifampin; Trimethoprim | 1996 |
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment.
Topics: Ampicillin; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Greece; Haemophilus influenzae; Microbial Sensitivity Tests; Norway; Poland; Sweden; Switzerland; Tetracycline; Trimethoprim; Turkey; United Kingdom; United States | 1996 |
Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Erythromycin; Haemophilus ducreyi; Humans; Microbial Sensitivity Tests; Penicillins; Reproducibility of Results; Tetracycline; Trimethoprim | 1996 |
Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; Dose-Response Relationship, Drug; Escherichia coli; Linear Models; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline; Tobramycin; Trimethoprim | 1997 |
Bilateral anterior uveitis and retinal haemorrhages after administration of trimethoprim.
Topics: Administration, Topical; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Ophthalmic Solutions; Recurrence; Retinal Hemorrhage; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Uveitis, Anterior | 1997 |
Antibiotic sensitivity and proticine typing of Proteus mirabilis strains associated with rheumatoid arthritis.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Arthritis, Rheumatoid; Bacteriocins; Case-Control Studies; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Proteus Infections; Proteus mirabilis; Serotyping; Trimethoprim | 1998 |
Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans.
Topics: Administration, Oral; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Physiological Phenomena; Biofilms; Chromatography, High Pressure Liquid; Ciprofloxacin; Electron Probe Microanalysis; Humans; Microscopy, Electron, Scanning; Ofloxacin; Stents; Trimethoprim; Ureter | 1998 |
Transferable trimethoprim resistance in Shigella strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Conjugation, Genetic; Drug Therapy, Combination; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Plasmids; Shigella; Trimethoprim; Trimethoprim Resistance | 1998 |
In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Lung Diseases; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulfonamides; Trimethoprim | 1998 |
Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women.
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Insurance, Health, Reimbursement; Medicaid; Middle Aged; Nitrofurantoin; North Carolina; Polypharmacy; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; United States; Urinary Tract Infections | 1999 |
Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin.
Topics: Amdinocillin; Animals; Anti-Infective Agents, Urinary; Bacteria; Biodegradation, Environmental; Chlorophyta; Ciprofloxacin; Humans; Risk Assessment; Sewage; Trimethoprim; Urinary Tract Infections; Water Pollution, Chemical; Zebrafish; Zooplankton | 2000 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cephalexin; Cephradine; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim; Urinary Tract Infections | 2001 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
Effect of ciprofloxacin on adhesive properties of non-P mannose-resistant uropathogenic Escherichia coli isolates.
Topics: Adhesins, Bacterial; Anti-Infective Agents; Anti-Infective Agents, Urinary; Catheterization; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hemagglutinins; Humans; Mannose; Microbial Sensitivity Tests; Microscopy, Electron; Trimethoprim; Urinary Catheterization; Urinary Tract Infections | 2003 |
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Bile Acids and Salts; Chromosome Mapping; Ciprofloxacin; Escherichia coli O157; Fosfomycin; Genome, Bacterial; Molecular Sequence Data; Recombination, Genetic; Shiga Toxin; Shiga Toxin 1; Shiga Toxin 2; Sulfamethoxazole; Trimethoprim; Virulence; Virus Integration | 2003 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |
In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Cephalexin; Ciprofloxacin; Dihydrostreptomycin Sulfate; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Female; Finland; Gentamicins; Israel; Mastitis, Bovine; Microbial Sensitivity Tests; Sulfadiazine; Tetracycline; Trimethoprim | 2003 |
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia).
Topics: Bacterial Outer Membrane Proteins; Burkholderia cepacia complex; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Profiling; Humans; Infant; Multigene Family; Reverse Transcriptase Polymerase Chain Reaction; Salicylates; Sequence Analysis, DNA; Trimethoprim | 2004 |
Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar typhi isolates showing reduced susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Salmonella typhi; Trimethoprim | 2004 |
Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2005 |
Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges.
Topics: Anti-Bacterial Agents; Caffeine; Chromatography, Liquid; Ciprofloxacin; Clindamycin; Environmental Monitoring; Spectrum Analysis; Sulfamethoxazole; Tetracycline; Trimethoprim; Waste Disposal, Fluid; Water Movements; Water Pollutants, Chemical; Water Pollution; Water Purification | 2006 |
Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus.
Topics: Bacterial Toxins; Ciprofloxacin; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Viral; Hemolysin Proteins; Lysogeny; Microbial Sensitivity Tests; SOS Response, Genetics; Sphingomyelin Phosphodiesterase; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus Phages; Trimethoprim; Virulence | 2006 |
Environmental monitoring study of selected veterinary antibiotics in animal manure and soils in Austria.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Austria; Chickens; Ciprofloxacin; Enrofloxacin; Environmental Monitoring; Environmental Pollutants; Fluoroquinolones; Manure; Soil; Soil Pollutants; Sulfonamides; Swine; Tetracyclines; Trimethoprim; Turkeys | 2007 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Deoxyribonucleases, Type II Site-Specific; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Fusidic Acid; Humans; Interspersed Repetitive Sequences; Methicillin; Methicillin Resistance; Molecular Epidemiology; Molecular Sequence Data; Penicillin-Binding Proteins; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Switzerland; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Indicator Dilution Techniques; Microbial Sensitivity Tests; Poultry; Quality Control; Salmonella enterica; Sulfamethizole; Tetracycline; Trimethoprim | 2007 |
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy.
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Cystoscopy; Humans; Trimethoprim | 2008 |
[A case of Salmonella paratyphi A infection in Poland].
Topics: Adult; Amoxicillin; Ceftriaxone; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Humans; Male; Paratyphoid Fever; Salmonella paratyphi A; Sulfamethizole; Travel; Trimethoprim | 2008 |
Antibacterial activity of ciprofloxacin and trimethoprim, alone and in combinittion, against Vibrio cholerae O1 biotype El Tor serotype Ogawa isolates.
Topics: Anti-Infective Agents, Urinary; Cholera; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Trimethoprim; Vibrio cholerae O1 | 2009 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Prescriptions; Drug Resistance, Bacterial; Family Practice; Female; Humans; Ireland; Male; Microbial Sensitivity Tests; Middle Aged; Multilevel Analysis; Retrospective Studies; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli; Young Adult | 2010 |
Different classes of antibiotics differentially influence shiga toxin production.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Oxidation kinetics of antibiotics during water treatment with potassium permanganate.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Hydrogen-Ion Concentration; Kinetics; Lincomycin; Manganese; Models, Chemical; Oxidation-Reduction; Potassium Permanganate; Temperature; Trimethoprim; Water; Water Purification; Water Supply | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.
Topics: Anti-Bacterial Agents; Berberine; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Ellagic Acid; Flavonoids; Gallic Acid; Hydroxybenzoates; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Rutin; Sulfamethoxazole; Tetracycline; Trimethoprim | 2010 |
Inequality in quality? Regional and educational differences in treatment with fluoroquinolone in urinary tract infection of 236,376 Swedish patients.
Topics: Adolescent; Adult; Age Distribution; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Utilization; Female; Fluoroquinolones; Guideline Adherence; Healthcare Disparities; Humans; Middle Aged; Multivariate Analysis; Nitrofurantoin; Norfloxacin; Practice Patterns, Physicians'; Quality Indicators, Health Care; Risk Adjustment; Social Class; Sweden; Trimethoprim; Urinary Tract Infections | 2011 |
Oxidation of antibiotics during water treatment with potassium permanganate: reaction pathways and deactivation.
Topics: Anti-Bacterial Agents; Biological Assay; Ciprofloxacin; Escherichia coli; Lincomycin; Manganese; Oxidation-Reduction; Potassium Permanganate; Trimethoprim; Water Pollutants, Chemical; Water Purification; Water Supply | 2011 |
An unusual adverse effect of long-term corticosteroid use.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Groin; Humans; Malacoplakia; Prednisolone; Skin Diseases; Time Factors; Treatment Outcome; Trimethoprim | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome.
Topics: Aged; Ciprofloxacin; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Greece; Humans; Logistic Models; Male; Netilmicin; Retrospective Studies; Statistics, Nonparametric; Stenotrophomonas maltophilia; Treatment Outcome; Trimethoprim | 2012 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Incidence; Male; Microbial Sensitivity Tests; Nitrofurantoin; Prevalence; Retrospective Studies; Time Factors; Trimethoprim; Urinary Tract Infections | 2013 |
Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Drug Prescriptions; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Risk Factors; Trimethoprim; Urinary Tract Infections | 2012 |
Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Typing Techniques; Bangladesh; Base Sequence; beta-Lactamases; Cholera; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Erythromycin; Furazolidone; Genetic Variation; Gentamicins; Humans; Microbial Sensitivity Tests; Sequence Alignment; Sequence Analysis, DNA; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2012 |
Resistance profiles of urinary tract infections in general practice--an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fosfomycin; General Practice; Germany; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Prospective Studies; Trimethoprim; Urinary Tract Infections; Young Adult | 2012 |
In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; DNA Primers; Gentamicins; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rifampin; Sheep; Sheep Diseases; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Turkey | 2013 |
Phenotypic detection of plasmid-acquired AmpC in Escherichia coli--evaluation of screening criteria and performance of two commercial methods for the phenotypic confirmation of AmpC production.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Plasmids; Trimethoprim | 2013 |
Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China.
Topics: Acetaminophen; Caffeine; Carbamazepine; Carbon; China; Ciprofloxacin; DEET; Environmental Monitoring; Erythromycin; Nitrates; Nitrites; Nitrogen; Pharmaceutical Preparations; Quaternary Ammonium Compounds; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Quality | 2013 |
A Cell Phone-Based Microphotometric System for Rapid Antimicrobial Susceptibility Testing.
Topics: Ampicillin; Anti-Bacterial Agents; Automation, Laboratory; Cell Phone; Chromogenic Compounds; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Lab-On-A-Chip Devices; Microarray Analysis; Microbial Sensitivity Tests; Microbial Viability; Microspectrophotometry; Oxidation-Reduction; Point-of-Care Systems; Sulfamethizole; Tetrazolium Salts; Trimethoprim; Urinary Tract Infections | 2014 |
The culturable soil antibiotic resistome: a community of multi-drug resistant bacteria.
Topics: Bacteria; Base Sequence; Ciprofloxacin; Cluster Analysis; DNA Primers; Drug Resistance, Bacterial; Genes, MDR; Genome, Bacterial; Molecular Sequence Data; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soil Microbiology; Species Specificity; Switzerland; Trimethoprim | 2013 |
Prevalence and molecular characterization of fluoroquinolone resistance in Escherichia coli isolates from dairy cattle with endometritis in China.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cattle Diseases; China; Ciprofloxacin; Dairying; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Endometritis; Escherichia coli; Escherichia coli Infections; Female; Prevalence; Trimethoprim | 2014 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
Effects of enrofloxacin, ciprofloxacin, and trimethoprim on two generations of Daphnia magna.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Daphnia; Enrofloxacin; Fluoroquinolones; Reproduction; Trimethoprim; Water Pollutants, Chemical | 2015 |
Assessing the concentrations and risks of toxicity from the antibiotics ciprofloxacin, sulfamethoxazole, trimethoprim and erythromycin in European rivers.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Environmental Monitoring; Erythromycin; Europe; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Pollution, Chemical | 2015 |
Quality of Antimicrobial Products Used in Striped Catfish (Pangasianodon hypophthalmus) Aquaculture in Vietnam.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Aquaculture; Catfishes; Cephalexin; Ciprofloxacin; Doxycycline; Quality Control; Reference Standards; Sulfonamides; Thiamphenicol; Trimethoprim; Veterinary Drugs; Vietnam | 2015 |
Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clinical Audit; Drug Resistance, Bacterial; England; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Health Policy; Humans; Meropenem; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Thienamycins; Trimethoprim; Urinary Tract Infections | 2015 |
Protective role of E. coli outer membrane vesicles against antibiotics.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Melitten; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Proteomics; Pseudomonas aeruginosa; Streptomycin; Trimethoprim | 2015 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Dysentery, Bacillary; Female; Humans; Microbial Sensitivity Tests; Pregnancy; Retrospective Studies; Salmonella; Salmonella Infections; Shigella; Sulfamethoxazole; Trimethoprim; Young Adult | 2016 |
Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.
Topics: 2-Aminopurine; 4-Nitroquinoline-1-oxide; Anti-Bacterial Agents; Azacitidine; Bromodeoxyuridine; Chloramphenicol; Ciprofloxacin; Cytidine; DNA Breaks, Double-Stranded; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Mutagens; Tetracycline; Trimethoprim; Vancomycin | 2015 |
Growth Behavior of E. coli, Enterococcus and Staphylococcus Species in the Presence and Absence of Sub-inhibitory Antibiotic Concentrations: Consequences for Interpretation of Culture-Based Data.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drinking Water; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sewage; Sulfamethoxazole; Trimethoprim; Vancomycin-Resistant Enterococci; Water Microbiology | 2016 |
Spatiotemporal microbial evolution on antibiotic landscapes.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Bacterial; Evolution, Molecular; Genotype; Microbial Sensitivity Tests; Microbial Viability; Mutation; Phenotype; Selection, Genetic; Trimethoprim | 2016 |
Nocardia Bacteremia and Endocarditis in a Patient With a Sulfa Allergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Hypersensitivity; Dyspnea; Endocarditis, Bacterial; Female; Humans; Middle Aged; Mitral Valve; Nocardia; Nocardia Infections; Sulfamethoxazole; Trimethoprim | 2016 |
Antimicrobial-resistant Escherichia coli and Enterococcus spp. isolated from Miranda donkey (Equus asinus): an old problem from a new source with a different approach.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus; Equidae; Escherichia coli; Kanamycin Kinase; Methyltransferases; Microbial Sensitivity Tests; Portugal; Sulfamethoxazole; Tetracycline; Trimethoprim; Virginiamycin | 2017 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Global gene expression profiling and antibiotic susceptibility after repeated exposure to the carbon monoxide-releasing molecule-2 (CORM-2) in multidrug-resistant ESBL-producing uropathogenic Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Cefotaxime; Cell Death; Cell Line; Ciprofloxacin; Cytokines; Drug Resistance, Multiple, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Ontology; Humans; Kidney; Microbial Sensitivity Tests; Microbial Viability; Movement; Organometallic Compounds; Phenotype; Real-Time Polymerase Chain Reaction; Transcription, Genetic; Trimethoprim; Uropathogenic Escherichia coli; Virulence | 2017 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Cephradine; Ciprofloxacin; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2018 |
The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models.
Topics: Anions; Anti-Bacterial Agents; Biological Transport; Cations; Cell Line; Ciprofloxacin; Drug Interactions; HEK293 Cells; Humans; Kinetics; Methotrexate; Organic Anion Transporters; Peptides; Trimethoprim | 2018 |
Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Genetic Loci; Genome, Bacterial; Genomics; Mutation; Mutation Rate; Trimethoprim | 2018 |
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Predisposition to Disease; Genetic Variation; Humans; Microbial Sensitivity Tests; Models, Statistical; Multivariate Analysis; Mutation; Nitrofurantoin; Phylogeny; Trimethoprim; Urinary Tract Infections | 2018 |
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Conjunctiva; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Tobramycin; Trimethoprim; United States | 2018 |
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin | 2019 |
Comparing the selective and co-selective effects of different antimicrobials in bacterial communities.
Topics: Anti-Infective Agents; Bacteria; Benzalkonium Compounds; Biota; Ciprofloxacin; Drug Resistance, Bacterial; Evolution, Molecular; Genes, Bacterial; Metagenomics; Selection, Genetic; Trimethoprim; Wastewater | 2019 |
Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Comorbidity; Critical Illness; Drug Combinations; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Intensive Care Units, Pediatric; Male; Minocycline; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Sulfadoxine; Trimethoprim | 2019 |
Multidrug Adaptive Resistance of Pseudomonas aeruginosa Swarming Cells.
Topics: Aminoglycosides; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Macrolides; Mutation; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; RNA-Seq; Tetracycline; Tobramycin; Trimethoprim | 2020 |
Comparing root concentration factors of antibiotics for lettuce (Lactuca sativa) measured in rhizosphere and bulk soils.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Lactuca; Plant Roots; Rhizosphere; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim; Tylosin | 2021 |
Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Citalopram; Clonazepam; DNA; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Plasmids; Sulfamethoxazole; Trimethoprim | 2021 |
Photodegradation of Ciprofloxacin, Clarithromycin and Trimethoprim: Influence of pH and Humic Acids.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Darkness; Half-Life; Humic Substances; Hydrogen-Ion Concentration; Kinetics; Light; Trimethoprim | 2021 |
Bioengineered phytomolecules-capped silver nanoparticles using Carissa carandas leaf extract to embed on to urinary catheter to combat UTI pathogens.
Topics: Anti-Bacterial Agents; Apocynaceae; Biofilms; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Gentamicins; Green Chemistry Technology; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Particle Size; Phytochemicals; Plant Extracts; Plant Leaves; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim; Urinary Catheters; Urinary Tract Infections | 2021 |
The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
Topics: Adult; Anti-Bacterial Agents; Bacteriology; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hidradenitis Suppurativa; Humans; Referral and Consultation; Rifampin; Sulfamethoxazole; Trimethoprim | 2022 |
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Laos; Ofloxacin; Prevalence; Sulfamethoxazole; Trimethoprim | 2022 |
A HPLC-MS/MS method for screening of selected antibiotic adulterants in herbal drugs.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Methanol; Metronidazole; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water | 2022 |
Influence of the hydraulic retention time on the removal of emerging contaminants in an anoxic-aerobic algal-bacterial photobioreactor coupled with anaerobic digestion.
Topics: Acetaminophen; Anaerobiosis; Bacteria, Aerobic; Bioreactors; Ciprofloxacin; Dexamethasone; Enrofloxacin; Ibuprofen; Naproxen; Photobioreactors; Progesterone; Sewage; Sulfamethoxazole; Tetracyclines; Trimethoprim; Tylosin; Waste Disposal, Fluid | 2022 |
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections | 2022 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Effects of ciprofloxacin, trimethoprim, and amoxicillin on microbial structure and growth as emerging pollutants reaching crop soils.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Environmental Pollutants; Fatty Acids; Phospholipids; Soil; Soil Microbiology; Soil Pollutants; Trimethoprim | 2022 |
The antibacterials ciprofloxacin, trimethoprim and sulfadiazine modulate gene expression, biomarkers and metabolites associated with stress and growth in gilthead sea bream (Sparus aurata).
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ciprofloxacin; Ecosystem; Gene Expression; Glutathione Reductase; Perciformes; Sea Bream; Stress, Physiological; Sulfadiazine; Trimethoprim; Water Pollutants, Chemical | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Characterization of oxacillin-resistant Staphylococcus lugdunensis isolated from sterile body fluids in a medical center in Taiwan: A 12-year longitudinal epidemiological study.
Topics: Anti-Bacterial Agents; Body Fluids; Ciprofloxacin; Erythromycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus lugdunensis; Sulfamethoxazole; Taiwan; Teicoplanin; Trimethoprim; Vancomycin | 2023 |
Characterization and Transferability of erm and tet Antibiotic Resistance Genes in Lactobacillus spp. Isolated from Traditional Fermented Milk.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Lactobacillus; Microbial Sensitivity Tests; Milk; RNA, Ribosomal, 16S; Sodium Chloride; Streptomycin; Trimethoprim; Vancomycin | 2022 |
Defects in DNA double-strand break repair resensitize antibiotic-resistant Escherichia coli to multiple bactericidal antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Repair; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim | 2022 |
Direct toxicity of six antibiotics on soil bacterial communities affected by the addition of bio-adsorbents.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biomass; Ciprofloxacin; Clarithromycin; Soil; Soil Pollutants; Trimethoprim | 2023 |
Pharmacokinetics, withdrawal time, and dietary risk assessment of enrofloxacin and its metabolite ciprofloxacin, and sulfachloropyridazine-trimethoprim in Taihe black-boned silky fowls.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Humans; Sulfachlorpyridazine; Trimethoprim | 2023 |
Genetic analysis of multidrug-resistant and AmpC-producing Citrobacter freundii.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Child, Preschool; Ciprofloxacin; Citrobacter freundii; Dogs; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Tetracycline; Trimethoprim | 2023 |
Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study.
Topics: Aged; Algorithms; Ampicillin; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Cohort Studies; Female; Gentamicins; Humans; Imipenem; Machine Learning; Male; Middle Aged; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2023 |